ATE307604T1

Use of Angiotensin II type 1 receptor antagonists for the prevention of diabetes

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 25 August 2020, 6.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

105 members in 36 offices

This recordMember, by publication datePriority claim26 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
9903028SwedenA
0008341European Patent Office (EPO)W

Members105

Family members, oldest first
DocumentOfficeKind
SE9903028D0SwedenD0
CA2382387A1CanadaA1
WO0115673A2World Intellectual Property Organization (WIPO)A2
AU7648400AAustraliaA
NO20020850D0NorwayD0
NO20020850LNorwayL
NO20100569LNorwayL
WO0115673A3World Intellectual Property Organization (WIPO)A3
BR0013540ABrazilA
CZ2002644A3CzechiaA3
EP1212081A2European Patent Office (EPO)A2
TR2002000518T2TürkiyeT2
TR200200518T2TürkiyeT2
KR20020060167ARepublic of KoreaA
MXPA02001633AMexicoA
SK2702002A3SlovakiaA3
IL148126A0IsraelA0
IL148126D0IsraelD0
CN1384756AChinaA
TR2002002466T2TürkiyeT2
TR2002002467T2TürkiyeT2
TR200202466T2TürkiyeT2
TR200202467T2TürkiyeT2
HU0202461A2HungaryA2
HUP0202461A2HungaryA2
BG106319ABulgariaA
TR2002002463T2TürkiyeT2
TR2002002464T2TürkiyeT2
TR200202463T2TürkiyeT2
TR200202464T2TürkiyeT2
JP2003508426AJapanA
EE200200085AEstoniaA
HU0202461A3HungaryA3
HUP0202461A3HungaryA3
ZA200201471BSouth AfricaB
HK1050327AHong Kong, ChinaA
HK1050327A1Hong Kong, ChinaA1
PL353066A1PolandA1
RU2002107673ARussian FederationA
EP1437131A1European Patent Office (EPO)A1
YU3602AYugoslavia, later Serbia and Montenegro (until 2006)A
CA2382387CCanadaC
AU2005203694A1AustraliaA1
EP1212081B1European Patent Office (EPO)B1
HRP20020169A2CroatiaA2
AT307604TAustriaT
ATE307604T1This recordAustriaT1
DE60023518D1GermanyD1
EP1212081B8European Patent Office (EPO)B8
DK1212081T3DenmarkT3
RU2272651C2Russian FederationC2
ES2250192T3SpainT3
SI1212081T1SloveniaT1
DE60023518T2GermanyT2
US2006194868A1United States of AmericaA1
UA76702C2UkraineC2
RU2005128124ARussian FederationA
KR20080035703ARepublic of KoreaA
EP1925303A2European Patent Office (EPO)A2
US2008125472A1United States of AmericaA1
CN100408093CChinaC
EE05130B1EstoniaB1
AU2009200551A1AustraliaA1
CN101537181AChinaA
UA88270C2UkraineC2
US2009258919A1United States of AmericaA1
RU2378018C2Russian FederationC2
BG110479ABulgariaA
NZ571901ANew ZealandA
NO329245B1NorwayB1
AU2009200551B2AustraliaB2
ME00181BMontenegroB
MEP28208AMontenegroA
US2010267798A1United States of AmericaA1
EP1925303A3European Patent Office (EPO)A3
EP2277519A2European Patent Office (EPO)A2
BG66115B1BulgariaB1
EP2277519A3European Patent Office (EPO)A3
US2011263619A1United States of AmericaA1
JP4843172B2JapanB2
EP1437131B1European Patent Office (EPO)B1
AT554761TAustriaT
ATE554761T1AustriaT1
PT1437131EPortugalE
DK1437131T3DenmarkT3
ES2386141T3SpainT3
CZ303433B6CzechiaB6
SI1437131T1SloveniaT1
HU229107B1HungaryB1
US2013317047A1United States of AmericaA1
RS52907BSerbiaB
EP1212081B2European Patent Office (EPO)B2
ES2250192T5SpainT5
DK1212081T4DenmarkT4
DE60023518T3GermanyT3
SI1212081T2SloveniaT2
EP1925303B1European Patent Office (EPO)B1
PT1925303EPortugalE
ES2525699T3SpainT3
IL148126AIsraelA
Showing 100 of 105